Innoviva (INVA) Cost of Revenue (2022 - 2025)
Innoviva (INVA) has disclosed Cost of Revenue for 5 consecutive years, with $25.6 million as the latest value for Q3 2025.
- For the quarter ending Q3 2025, Cost of Revenue rose 49.23% year-over-year to $25.6 million, compared with a TTM value of $59.8 million through Sep 2025, up 27.79%, and an annual FY2025 reading of $77.4 million, up 111.44% over the prior year.
- Cost of Revenue was $25.6 million for Q3 2025 at Innoviva, up from $8.1 million in the prior quarter.
- Across five years, Cost of Revenue topped out at $25.6 million in Q3 2025 and bottomed at -$7.1 million in Q2 2023.
- Average Cost of Revenue over 3 years is $10.1 million, with a median of $8.8 million recorded in 2025.
- The sharpest move saw Cost of Revenue surged 218.51% in 2024, then dropped 19.41% in 2025.
- Year by year, Cost of Revenue stood at $10.2 million in 2023, then soared by 68.77% to $17.2 million in 2024, then soared by 49.23% to $25.6 million in 2025.
- Business Quant data shows Cost of Revenue for INVA at $25.6 million in Q3 2025, $8.1 million in Q2 2025, and $8.8 million in Q1 2025.